argenx SE reported 5.83B in Current Assets for its fiscal quarter ending in June of 2025.


Current Assets Change Date
AstraZeneca USD 28.94B 2.8B Jun/2025
Galapagos EUR 3.26B 217.04M Jun/2025
Genmab DKK 3.91B 127M Jun/2025
GlaxoSmithKline GBP 17.67B 412M Jun/2025
GRIFOLS EUR 5.25B 393.8M Jun/2025
Hikma Pharmaceutical USD 2.26B 22M Dec/2024
Qiagen NV USD 1.82B 76.12M Jun/2025
UCB EUR 4.79B 1.47B Dec/2024